Bangkok Dusit Medical Services Public Co. Ltd.

Bangkok Dusit Medical Services Public Co. Ltd.

19.40
THB
-0.10
(-0.51%)
0.99EPS
20.02P/E
306.72BMarket Cap
Nov 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.27
3.62
4.06
4.38
4.64
4.97
5.25
4.28
4.68
5.78
6.35
6.79
7.02
7.03
Basic EPS, GAAP
0.4
0.48
0.52
0.54
0.66
0.59
0.99
0.45
0.5
0.79
0.9
1.01
1
0.96
Free Cash Flow per Basic Share
0.04
0.15
0.42
0.22
-0.3
0.46
0.42
0.32
0.64
0.96
0.79
0.71
0.76
0.75
Dividend per Share
0.18
0.2
0.23
0.36
0.32
0.36
0.44
0.3
0.8
0.5
0.65
0.7
0.75
0.35
Book Value per Share
2.63
2.94
3.39
3.6
4.07
4.49
5.27
5.53
5.28
5.67
6.01
6.29
6.66
6.5
Tangible Book Value per Share
1.83
1.8
2.19
2.38
2.82
3.23
4.02
4.34
4.09
4.46
4.79
5.05
5.39
5.21
Basic Weighted Avg Shares
15,463
15,491
15,491
15,491
15,491
15,570
15,743
15,892
15,892
15,892
15,892
15,892
15,892
15,892
Sales/Revenue/Turnover
50,615
56,054
62,834
67,904
71,933
77,373
82,723
68,074
74,451
91,934
100,853
107,867
111,507
111,798
Operating Margin (%)
15.08
15.99
15.65
14.61
14.33
15.24
14.57
12.52
15.07
18.47
18.73
18.96
18.08
17.44
Depreciation Expense
3,244
3,716
4,387
4,803
5,168
5,386
5,752
6,413
6,321
5,950
5,848
6,132
6,848
7,221
Net Income, GAAP
6,261
7,394
8,021
8,386
10,216
9,191
15,517
7,214
7,936
12,606
14,358
15,987
15,848
15,318
Effective Tax Rate (%)
17.59
17.89
18.53
17.98
19.51
22.12
19.48
26.45
19.85
19.58
20.22
18.65
18.41
18.59
Profit Margin (%)
12.37
13.19
12.76
12.35
14.2
11.88
18.76
10.6
10.66
13.71
14.24
14.82
14.21
13.7
Working Capital
-1,513
-1,160
-1,712
-5,282
977
-13,301
-2,938
18,792
8,539
7,183
5,112
1,646
-520
-3,870
LT Debt
18,789
27,411
27,060
25,933
37,711
24,753
19,130
23,736
15,384
17,182
15,317
13,540
10,608
10,724
Total Equity
42,685
47,717
54,997
58,305
65,871
73,438
87,182
91,463
87,765
93,949
99,091
103,927
110,009
107,276
Return on Invested Capital (%)
10.13
10.13
9.72
9.26
10.84
8.38
14.04
7.04
8.04
12.12
12.76
13.82
13.12
12.74
Return on Capital (%)
10.97
10.92
10.5
9.96
11.35
8.82
14.02
6.53
7.17
11.12
12.16
13.18
12.51
12.16
Return on Common Equity (%)
16.15
17.16
16.37
15.5
17.2
13.78
20.13
8.4
9.24
14.49
15.48
16.36
15.39
14.96

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
6,879
3,345
8,357
LT Borrowings
3,000
3,000
3,000
LT Finance Leases
7,608
7,676
7,724
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15,892
15,892
15,892
Market Capitalization
306,716
298,770
306,716

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
23,109
25,273
21,732
Cash, Cash Equivalents & STI
7,242
8,122
4,705
Accounts Receivable, Net
11,638
12,313
12,072
Inventories
3,422
3,880
3,918
Total Current Liabilities
23,629
21,838
25,602
Payables & Accruals
15,236
17,325
16,185
ST Debt
6,879
3,345
8,357
Deferred Revenue
190
193
190

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.33%
3.84%
5.85%
Free Cash Flow
-43.39%
26.13%
6.62%
Net Income, GAAP
12.49%
18.65%
-0.87%
Sales/Revenue/Turnover
6.36%
10.58%
3.37%
Total Cash Common Dividend
22.66%
35.18%
7.17%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
26,609
25,704
28,151
27,404
107,867
2025
28,084
26,727
28,243
28,453
111,507
2026
28,179
26,923
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.26
0.21
0.27
0.27
1.01
2025
0.27
0.22
0.27
0.23
1
2026
0.26
0.2
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.35
0.35
- -
0.7
2025
- -
- -
0.35
- -
0.75
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kongkiat Kespechara
Full Time Employees
11,628
Sector
Health services
Industry
Hospital/Nursing management
Address
2, Soi Soonvijai 7 Bangkok BM Thailand 10310
IPO Date
Oct 2, 1991
Business
Bangkok Dusit Medical Services Public Company Limited (BDMS.BK) operates Thailand's largest private hospital network, providing comprehensive healthcare services through its hospital operations and supporting businesses segments. The company manages six major hospital groups--Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group--along with BDMS Wellness Clinic; it offers specialized treatments in areas such as holistic clinical wellness, cancer care at Bangkok Cancer Hospital Wattanosoth, emergency services, genomic medicine, skin and aesthetics telemedicine, and centers of excellence for complex conditions including proton therapy planned for launch in 2029. Additional services encompass medical laboratories, air medical transportation and ambulances via BDMS Medevac Center, health insurance brokerage, pharmaceutical production and distribution, pharmacies, e-commerce for health products, real estate, hotels, facility management, and investment in wellness residences like BDMS Silver Wellness & Residence. BDMS serves over 10 million patients annually, including more than 2 million international patients from Asia-Pacific and beyond, with a strong focus on medical tourism in key destinations such as Bangkok, Pattaya, Phuket, and the Eastern Economic Corridor (EEC). The network spans approximately 50 facilities primarily in Thailand across central, northern, northeastern, eastern, western, and southern regions, plus operations in Cambodia and plans for further international outreach. Founded in 1969 and headquartered at 2 Soi Soonvijai 7, New Phetchaburi Road, Bangkok, Thailand, BDMS continues to expand strategically. Recent developments include receiving a 1,000 million baht green loan from TMBThanachart Bank in 2025 to develop Bangkok International Hospital (BIH) as Thailand's first LEED Healthcare Gold-certified green hospital with 172 beds and smart technology features; announcing the opening of Phayathai Bowin Hospital, a 220-bed greenfield facility in Chonburi (59 beds in phase one); bed expansions in EEC locations like Bangkok Pattaya, Jomtien, and Rayong to reach approximately 600 beds each; strengthening partnerships such as ongoing collaborations with CNN for health programming and Prudential for regional cancer treatment access; and reporting stable 3Q25 net profit growth of 1.72% year-over-year to THB 4,319 million amid cost controls and investment promotions. Subsidiaries like National Healthcare Systems for blood diagnostics and A.N.B. Laboratories & Medicpharma for pharmaceuticals support its integrated ecosystem.